Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease

Clinical trial NCT01559129 · TERMINATED

Trial details

NCT number: NCT01559129
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic Sclerosis, Systemic Systemic Scleroderma Systemic Sclerosis Interstitial Lung Disease

Start date: 2012-08-09
Primary completion: 2016-11-03
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.